Upload
Featured Recent Articles Topics Upload Login Sign Up

Search Results for 'fda clinical'

fda clinical published presentations and documents on DocSlides.

Post-FDA Approval, Initial US Clinical Experience with Watc
Post-FDA Approval, Initial US Clinical Experience with Watc
by phoebe-click
Vivek Y. Reddy MD. 1. *, Douglas N. Gibson MD. 2....
Post-FDA Approval, Initial US Clinical Experience with Watchman Left Atrial Appendage Closure for S
Post-FDA Approval, Initial US Clinical Experience with Watchman Left Atrial Appendage Closure for S
by kittie-lecroy
Vivek Y. Reddy MD. 1. *, Douglas N. Gibson MD. 2....
Preparing for an FDA Inspection
Preparing for an FDA Inspection
by tawny-fly
. Kathy Gilmartin, MSN, CRN...
Preparing for an FDA Inspection
Preparing for an FDA Inspection
by min-jolicoeur
. Kathy Gilmartin, MSN, CRN...
Preparing for an FDA Inspection
Preparing for an FDA Inspection
by felicity
. Kathy Gilmartin, MSN, CRNP, CCRC. ...
FDA Pre-Submission Meetings
FDA Pre-Submission Meetings
by violet
for 510(k) Submissions. Consultants and RA Experts...
Pharmacometrics and Biostatistics Interactions at the FDA
Pharmacometrics and Biostatistics Interactions at the FDA
by byrne
Jeffry Florian, Ph.D.. Division of Pharmacometrics...
1 FDA’s BIMO Inspection Program
1 FDA’s BIMO Inspection Program
by olivia-moreira
and. IRB Inspections. VA IRB Chairs Meeting. Aug...
Modeling and Simulation at U.S. FDA
Modeling and Simulation at U.S. FDA
by debby-jeon
Tina Morrison, Ph.D.. Chair, Modeling and Simulat...
FDA Overview of the Process for Clearance and Approval of Mass Spectrometry-based In vitro Diagnost
FDA Overview of the Process for Clearance and Approval of Mass Spectrometry-based In vitro Diagnost
by tatiana-dople
MSACL. April 4, 2019. Majda Haznadar, Kris Roth, ...
FDA’s Center for Devices and Radiological Health: Current Status and Future Direction
FDA’s Center for Devices and Radiological Health: Current Status and Future Direction
by carny
Jeff Shuren, MD, JD. Center for Devices and Radiol...
FDA's role in the innovation and
FDA's role in the innovation and
by josephine
evaluation of evolving . computer-aided diagnosis ...
FDA Perspective on the development and use of
FDA Perspective on the development and use of
by osullivan
Epidemiological cut-off values (ECVs). Simone M. S...
SHEDDING LIGHT ON AN FDA VISIT
SHEDDING LIGHT ON AN FDA VISIT
by CuteAsACupcake
Joyce Nancarrow Tull, MSN, RN, CCRP. University of...
The FDA is Coming Neala Lane, MS, CCRC
The FDA is Coming Neala Lane, MS, CCRC
by joy
Associate Director. Quality Improvement Office. Of...
FDA’s Access Mechanisms
FDA’s Access Mechanisms
by roxanne
When They Work – When They Don’t . And Why. St...
FDA Regulatory Requirements for Successful Biomarker Applications
FDA Regulatory Requirements for Successful Biomarker Applications
by oliver
Early Detection Research Network. September 9, 201...
What is FDA
What is FDA
by adriel473
. FDA. 10. The . Food . and . Drug . Administratio...
Clinical Trial Data Integrity:
Clinical Trial Data Integrity:
by phoebe-click
Bi. oresearch . Mo. nitoring Program. Jur Strobos...
1 Pediatric Clinical Investigator Training
1 Pediatric Clinical Investigator Training
by lois-ondreau
GCP: . Tips on Clinical Trial Conduct and . Prepa...
Clinical and Nonclinical Inspections
Clinical and Nonclinical Inspections
by claire
n and Research or CBER conducting clinical resear...
2011 American Association for Clinical Chemistry
2011 American Association for Clinical Chemistry
by mackenzie
Page 1of 8The Journey to Regulation of Protein-Bas...
Guidance for Clinical Investigators Sponsors and Investigational New D
Guidance for Clinical Investigators Sponsors and Investigational New D
by jade
NOTE A stay is in effect for partsof subsection V...
Digital health technology-derived clinical outcome assessments: considerations for regulatory decis
Digital health technology-derived clinical outcome assessments: considerations for regulatory decis
by jalin
Elektra Papadopoulos, MD, MPH. Acting Deputy Direc...
Global Regulatory Affairs
Global Regulatory Affairs
by min-jolicoeur
US . vs. EU. Nariko Koto, MBA. Global Regulatory/...
Summary of FDA and NIST efforts toward metrics and standard
Summary of FDA and NIST efforts toward metrics and standard
by tatiana-dople
. Content by . Marc . Salit. & Justin . Zoo...
Everyday Preparedness for the
Everyday Preparedness for the
by tatiana-dople
Challenges . of . FDA-Regulated . Research. Pat W...
Afternoon Breakout Session:
Afternoon Breakout Session:
by stefany-barnette
FDA and Regulatory Environment As We Enter the Us...
My Experiences as an FDA Statistician
My Experiences as an FDA Statistician
by aaron
Yeh-Fong Chen, Ph.D. . FDA/CDER/OB/DB3. CBA 2016-...
FDA Public Workshop – Variant Classification
FDA Public Workshop – Variant Classification
by lindy-dunigan
Session 4: Future directions for data sharing, st...
The IND and Clinical Trial Management
The IND and Clinical Trial Management
by kittie-lecroy
Frances Richmond . Director International Center ...
Faculty Leonard H. Calabrese, DO
Faculty Leonard H. Calabrese, DO
by trish-goza
Professor of Medicine. Cleveland Clinic Lerner Co...
1 Structure and mandate of FDA
1 Structure and mandate of FDA
by sherrill-nordquist
Leonard Sacks. Office of Medical Policy. CDER, FD...
UC DAVIS OFFICE OF RESEARCH
UC DAVIS OFFICE OF RESEARCH
by olivia-moreira
Overview of Good Clinical Practices (GCP) . Inves...
Department of Health and Human Services2 OFFICE OF 2INSPECTOR GENERAL
Department of Health and Human Services2 OFFICE OF 2INSPECTOR GENERAL
by anastasia
Daniel R LevinsonInspector General The mission of ...
Clinical/Surrogate Endpoints and Innovative Approaches for Catheter Ablation Studies
Clinical/Surrogate Endpoints and Innovative Approaches for Catheter Ablation Studies
by SugarPlumFairy
FDA Perspective. Marco Cannella, PhD. Senior Lead ...
Information Sheet Guidance for Institutional Review Boards Clinical I
Information Sheet Guidance for Institutional Review Boards Clinical I
by anastasia
http://www.fda.gov/ScienceResearch/SpecialTopics/R...
Department of Health and Human Services
Department of Health and Human Services
by lam
Daniel R. LevinsonInspector General January 2009 O...
Department of Health and Human Services
Department of Health and Human Services
by daisy
FDA’Daniel R. LevinsonInspector General OEI-0...
Writing and Holding an IND- IIT Development
Writing and Holding an IND- IIT Development
by osullivan
Week 3- Proposing and Conducting a Clinical Trial....